Citation: R. Angioli et al., HEREDITARY AND SPORADIC OVARIAN-CANCER - GENETIC TESTING AND CLINICALIMPLICATIONS (REVIEW), International journal of oncology, 12(5), 1998, pp. 1029-1034
Authors:
ESTAPE R
ANGIOLI R
WAGMAN F
MADRIGAL M
JANICEK M
GANJEIAZAR P
PENALVER M
AVERETTE H
Citation: R. Estape et al., SIGNIFICANCE OF INTRAPERITONEAL CYTOLOGY IN PATIENTS UNDERGOING RADICAL HYSTERECTOMY, Gynecologic oncology, 68(2), 1998, pp. 169-171
Authors:
ANGIOLI R
ESTAPE R
CANTUARIA G
MIRHASHEMI R
WILLIAMS H
MARTIN J
PENALVER M
Citation: R. Angioli et al., URINARY COMPLICATIONS OF MIAMI POUCH - TREND OF CONSERVATIVE MANAGEMENT, American journal of obstetrics and gynecology, 179(2), 1998, pp. 343-348
Authors:
ANGIOLI R
JANICEK M
SEVIN BU
ESTAPE R
AVERETTE HE
KOECHLI OR
UNTCH M
PENALVER M
Citation: R. Angioli et al., USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS, International journal of oncology, 11(4), 1997, pp. 777-780
Authors:
JANICEK MF
ANGIOLI R
UNAL AD
SEVIN BU
MADRIGAL M
ESTAPE R
AVERETTE HE
Citation: Mf. Janicek et al., P53 INTERFERENCE AND GROWTH-INHIBITION IN P53-MUTANT AND OVEREXPRESSING ENDOMETRIAL CANCER CELL-LINES, Gynecologic oncology, 66(1), 1997, pp. 94-102
Authors:
ANGIOLI R
SEVIN BU
UNTCH M
KOCHLI OR
ESTAPE R
AVERETTE HE
Citation: R. Angioli et al., USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER, Oncology Reports, 3(2), 1996, pp. 351-354